Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502018 · ClinicalTrials.gov registry record · Phase 4
Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty
A Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03502018 is a Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur that has completed, run by Maimonides Medical Center. The registered enrollment target is 50 participants, below the 403-participant average among 8 other Femoral Neck Fractures trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03502018, a Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior approach. Post-operative measures will be assessing pain, overall opiate use, delirium, time-to-ambulation and discharge status.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Bupivacaine liposome
Study Locations (1)
New York
- Maimonides Medical Center - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03502018
The ClinicalTrials.gov registry entry for NCT03502018 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 403-participant average among 8 other Femoral Neck Fractures trials with a reported enrollment target (88% lower). The listed sponsor is Maimonides Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Femoral Neck Fractures appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT03502018 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03502018 about?
NCT03502018 is a clinical study titled "Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty". This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior approach. Post-operative measures will be assessing pain, overall opiate use, delirium, time-to-ambulation and discharge sta...
What is the current status of trial NCT03502018?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-03-01. Estimated completion is 2023-08-31.
What conditions does trial NCT03502018 study?
This clinical trial studies the following conditions: Femoral Neck Fractures, Intracapsular Fracture of Femur, Hip Hemiarthroplasty.
What interventions are being tested in trial NCT03502018?
The interventions under investigation include: Saline (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT03502018?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03502018 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoral Neck Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Opioid-Free Pain Treatment in Trauma Patients
RECRUITING · NA
-
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
RECRUITING · NA
-
PENG vs FICB for Hip Fracture in ED Patients
RECRUITING · NA
-
FNS (FEMORAL NECK SYSTEM) Study
ACTIVE NOT RECRUITING
-
Insignia™ Hip Stem Outcomes Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.